OMIP-087: Thirty-two parameter mass cytometry panel to assess human CD4 and CD8 T cell activation, memory subsets,

Alexis Sponaugle1, Maria Abad-Fernandez2, Nilu Goonetilleke1,2

  • 1Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Insights

We created a reproducible 32-marker mass cytometry panel for detailed immune cell analysis. This tool aids in monitoring CD4 and CD8 T cells for various diseases using minimal patient samples.

Area of Science:

  • Immunology
  • Cell Biology
  • Biotechnology

Background:

  • Accurate characterization of immune cells, particularly T cells, is crucial for understanding and managing diseases like infections, cancer, and autoimmunity.
  • Existing methods may require significant sample volumes or lack the multiplexing capability to comprehensively analyze diverse immune subsets.
  • There is a need for standardized, high-resolution panels for immune cell profiling in peripheral blood mononuclear cells (PBMCs).

Purpose of the Study:

  • To develop and validate a highly reproducible 32-marker mass cytometry panel for comprehensive immune cell analysis.
  • To enable detailed characterization of CD4 and CD8 T cell subsets, including memory, activation, cell cycling, and survival markers.
  • To facilitate the classification of major CD4 T helper subsets within human PBMCs.

Main Methods:

  • Development of a 32-color mass cytometry panel optimized for human PBMCs.
  • Standardization and optimization protocols for high-throughput, reproducible immune profiling.
  • Identification and gating strategies for canonical immune lineages, CD4 T cell subsets, and CD8 T cell memory populations.

Main Results:

  • A highly reproducible 32-marker mass cytometry panel was successfully established.
  • The panel allows for the measurement of all canonical immune lineages.
  • Six distinct T cell memory subsets, activation, cell cycling, and survival markers were identified, alongside major CD4 T helper subsets.

Conclusions:

  • This mass cytometry panel provides a robust and reproducible method for detailed immune cell analysis, particularly for CD4 and CD8 T cells.
  • The panel's ability to characterize multiple immune parameters with limited sample input is valuable for clinical research.
  • It enables comprehensive monitoring of immune responses in infectious diseases, cancer, and autoimmune conditions.